FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024987105> ?p ?o ?g. }

• W2024987105 endingPage "722" @default.
• W2024987105 startingPage "717" @default.
• W2024987105 abstract "Objectives To assess the likelihood of biochemical disease-free survival, urinary continence, and sexual potency after radical retropubic prostatectomy (RRP) as an aggregate outcome, the “trifecta” analysis. Methods From the Columbia University Urologic Oncology Database of 2522 patients from 1988 to 2005, 503 had undergone RRP by a single surgeon. Of these, 87 patients were excluded: 31 with inadequate follow-up, 47 who had undergone additional confounding therapy, and 9 with insufficient data for the trifecta analysis. The final sample of 416 patients was stratified according to preoperative prostate-specific antigen level, Gleason sum, and clinical stage. Biochemical disease-free survival, continence, and potency were defined, respectively, as a prostate-specific antigen level of less than 0.2 ng/mL, not requiring daily pads, and having an erection sufficient for intercourse with or without oral pharmacotherapy. Patients achieving all three positive outcomes, the trifecta, were analyzed using analysis of variance. Results Risk stratification identified 225 low-risk, 144 intermediate-risk and 47 high-risk patients whose biochemical disease-free survival rate was 96.4%, 90.3%, and 78.7% at a median follow-up period of 4.4, 4.8, and 7.1 years, respectively. The corresponding continence rates were 93.8%, 94.4%, and 93.3% and the potency rates were 81.3%, 67.7%, and 69.6% with at least 1 year of follow-up. Of the 314 analyzable patients, 130 (72.6%) of 179 low-risk, 61 (58.1%) of 105 intermediate-risk, and 12 (40.0%) of 30 high-risk patients achieved the trifecta. The trifecta rates were significantly different between the low and intermediate-risk (P = 0.04) and low and high-risk (P = 0.001) groups. Conclusions Preoperative (RRP) low-risk patients are more likely to remain disease-free, continent, and potent after surgery than are patients of higher risk. Physicians should consider aggregate outcomes when counseling patients regarding the clinical outcomes after RRP. To assess the likelihood of biochemical disease-free survival, urinary continence, and sexual potency after radical retropubic prostatectomy (RRP) as an aggregate outcome, the “trifecta” analysis. From the Columbia University Urologic Oncology Database of 2522 patients from 1988 to 2005, 503 had undergone RRP by a single surgeon. Of these, 87 patients were excluded: 31 with inadequate follow-up, 47 who had undergone additional confounding therapy, and 9 with insufficient data for the trifecta analysis. The final sample of 416 patients was stratified according to preoperative prostate-specific antigen level, Gleason sum, and clinical stage. Biochemical disease-free survival, continence, and potency were defined, respectively, as a prostate-specific antigen level of less than 0.2 ng/mL, not requiring daily pads, and having an erection sufficient for intercourse with or without oral pharmacotherapy. Patients achieving all three positive outcomes, the trifecta, were analyzed using analysis of variance. Risk stratification identified 225 low-risk, 144 intermediate-risk and 47 high-risk patients whose biochemical disease-free survival rate was 96.4%, 90.3%, and 78.7% at a median follow-up period of 4.4, 4.8, and 7.1 years, respectively. The corresponding continence rates were 93.8%, 94.4%, and 93.3% and the potency rates were 81.3%, 67.7%, and 69.6% with at least 1 year of follow-up. Of the 314 analyzable patients, 130 (72.6%) of 179 low-risk, 61 (58.1%) of 105 intermediate-risk, and 12 (40.0%) of 30 high-risk patients achieved the trifecta. The trifecta rates were significantly different between the low and intermediate-risk (P = 0.04) and low and high-risk (P = 0.001) groups. Preoperative (RRP) low-risk patients are more likely to remain disease-free, continent, and potent after surgery than are patients of higher risk. Physicians should consider aggregate outcomes when counseling patients regarding the clinical outcomes after RRP." @default.
• W2024987105 created "2016-06-24" @default.
• W2024987105 creator A5011642832 @default.
• W2024987105 creator A5019183958 @default.
• W2024987105 creator A5029009031 @default.
• W2024987105 creator A5041880741 @default.
• W2024987105 creator A5060409090 @default.
• W2024987105 date "2007-10-01" @default.
• W2024987105 modified "2023-10-16" @default.
• W2024987105 title "Preoperative Risk Stratification Predicts Likelihood of Concurrent PSA-Free Survival, Continence, and Potency (the Trifecta Analysis) After Radical Retropubic Prostatectomy" @default.
• W2024987105 cites W1275039145 @default.
• W2024987105 cites W156230426 @default.
• W2024987105 cites W1972448981 @default.
• W2024987105 cites W1975323370 @default.
• W2024987105 cites W1979048558 @default.
• W2024987105 cites W1993540005 @default.
• W2024987105 cites W2049310327 @default.
• W2024987105 cites W2084977399 @default.
• W2024987105 cites W2102518781 @default.
• W2024987105 cites W2104022977 @default.
• W2024987105 cites W2115483503 @default.
• W2024987105 cites W2117792530 @default.
• W2024987105 cites W2137282952 @default.
• W2024987105 cites W2138029397 @default.
• W2024987105 cites W2146720344 @default.
• W2024987105 cites W2167323189 @default.
• W2024987105 cites W4233182856 @default.
• W2024987105 doi "https://doi.org/10.1016/j.urology.2007.06.639" @default.
• W2024987105 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17991543" @default.
• W2024987105 hasPublicationYear "2007" @default.
• W2024987105 type Work @default.
• W2024987105 sameAs 2024987105 @default.
• W2024987105 citedByCount "44" @default.
• W2024987105 countsByYear W20249871052012 @default.
• W2024987105 countsByYear W20249871052013 @default.
• W2024987105 countsByYear W20249871052014 @default.
• W2024987105 countsByYear W20249871052015 @default.
• W2024987105 countsByYear W20249871052017 @default.
• W2024987105 countsByYear W20249871052019 @default.
• W2024987105 countsByYear W20249871052020 @default.
• W2024987105 countsByYear W20249871052021 @default.
• W2024987105 countsByYear W20249871052022 @default.
• W2024987105 crossrefType "journal-article" @default.
• W2024987105 hasAuthorship W2024987105A5011642832 @default.
• W2024987105 hasAuthorship W2024987105A5019183958 @default.
• W2024987105 hasAuthorship W2024987105A5029009031 @default.
• W2024987105 hasAuthorship W2024987105A5041880741 @default.
• W2024987105 hasAuthorship W2024987105A5060409090 @default.
• W2024987105 hasConcept C121608353 @default.
• W2024987105 hasConcept C126322002 @default.
• W2024987105 hasConcept C126894567 @default.
• W2024987105 hasConcept C141071460 @default.
• W2024987105 hasConcept C185592680 @default.
• W2024987105 hasConcept C202751555 @default.
• W2024987105 hasConcept C2777008409 @default.
• W2024987105 hasConcept C2778660094 @default.
• W2024987105 hasConcept C2779466945 @default.
• W2024987105 hasConcept C2780192828 @default.
• W2024987105 hasConcept C2781406297 @default.
• W2024987105 hasConcept C2993211783 @default.
• W2024987105 hasConcept C50382708 @default.
• W2024987105 hasConcept C54847362 @default.
• W2024987105 hasConcept C55493867 @default.
• W2024987105 hasConcept C57992300 @default.
• W2024987105 hasConcept C71924100 @default.
• W2024987105 hasConcept C77350462 @default.
• W2024987105 hasConceptScore W2024987105C121608353 @default.
• W2024987105 hasConceptScore W2024987105C126322002 @default.
• W2024987105 hasConceptScore W2024987105C126894567 @default.
• W2024987105 hasConceptScore W2024987105C141071460 @default.
• W2024987105 hasConceptScore W2024987105C185592680 @default.
• W2024987105 hasConceptScore W2024987105C202751555 @default.
• W2024987105 hasConceptScore W2024987105C2777008409 @default.
• W2024987105 hasConceptScore W2024987105C2778660094 @default.
• W2024987105 hasConceptScore W2024987105C2779466945 @default.
• W2024987105 hasConceptScore W2024987105C2780192828 @default.
• W2024987105 hasConceptScore W2024987105C2781406297 @default.
• W2024987105 hasConceptScore W2024987105C2993211783 @default.
• W2024987105 hasConceptScore W2024987105C50382708 @default.
• W2024987105 hasConceptScore W2024987105C54847362 @default.
• W2024987105 hasConceptScore W2024987105C55493867 @default.
• W2024987105 hasConceptScore W2024987105C57992300 @default.
• W2024987105 hasConceptScore W2024987105C71924100 @default.
• W2024987105 hasConceptScore W2024987105C77350462 @default.
• W2024987105 hasIssue "4" @default.
• W2024987105 hasLocation W20249871051 @default.
• W2024987105 hasLocation W20249871052 @default.
• W2024987105 hasOpenAccess W2024987105 @default.
• W2024987105 hasPrimaryLocation W20249871051 @default.
• W2024987105 hasRelatedWork W1967410728 @default.
• W2024987105 hasRelatedWork W2024213847 @default.
• W2024987105 hasRelatedWork W2024987105 @default.
• W2024987105 hasRelatedWork W2026113581 @default.
• W2024987105 hasRelatedWork W2068763685 @default.
• W2024987105 hasRelatedWork W2092723120 @default.
• W2024987105 hasRelatedWork W3150909901 @default.
• W2024987105 hasRelatedWork W4214569507 @default.
• W2024987105 hasRelatedWork W4250929992 @default.

• next